Enoxaparin Sodium Injection IP 60 mg – Veinova 60 Injection

Enoxaparin Sodium Injection IP 60 mg – A reliable choice for the prevention and management of thromboembolic disorders.

Veinova 60 Injection –  Enoxaparin 60 mg contains Enoxaparin, a low molecular weight heparin (LMWH) known for its potent anticoagulant properties. It works by selectively inhibiting Factor Xa, thereby preventing the formation of new blood clots and the progression of existing ones. Enoxaparin is widely utilized in both the prevention and treatment of thromboembolic disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as in patients with reduced mobility or for those undergoing surgical procedures.

Recommended by Specialists:
✅Cardiologists – For managing acute coronary syndromes (ACS) and reducing the risk of thrombotic complications.
✅Vascular Surgeons – For DVT and PE prevention and treatment, especially in perioperative settings.
✅Orthopaedic Surgeons – To prevent thromboembolic events following major joint or orthopaedic surgeries.

Key Benefits of Enoxaparin Sodium Injection IP 60 mg – Veinova 60 Injection:
✅Reliable Anticoagulation: Offers predictable therapeutic effects with minimal requirement for routine coagulation monitoring—ideal for outpatient and long-term management.
✅Better Safety Profile: Demonstrates a lower incidence of heparin-induced thrombocytopenia (HIT) as compared to traditional unfractionated heparin.
✅Wide Clinical Application: Effective across diverse settings—from surgical prophylaxis to treatment of active thrombotic events.

Indications:
✅Prevention of Deep Vein Thrombosis (DVT)
✅Treatment of Pulmonary Embolism (PE)
✅Management of Acute Coronary Syndrome (ACS)